Please Wait
Applying Filters...
menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-24

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-17

    Virtual Booth

    Contact Supplier

    Menu

    Atomoxetin Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 818Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of February 26, 2025
    Enforcement Report - Week of February 26, 2025

    26 Feb 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-26-2025-78017.pdf

    FDA
    26 Feb 2025
    Share Share
    Apnimed Announces Positive Topline Results for MARIPOSA Trial of AD109
    Apnimed Announces Positive Topline Results for MARIPOSA Trial of AD109

    17 Oct 2022

    // PRESS RELEASE

    https://apnimed.com/apnimed-announces-positive-topline-results-for-mariposa-trial-of-ad109/

    PRESS RELEASE
    17 Oct 2022
    Share Share
    Apnimed to Participate in the Annual Needham Biotech Company Virtual 1x1 Forum
    Apnimed to Participate in the Annual Needham Biotech Company Virtual 1x1 Forum

    12 Oct 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221012005118/en

    BUSINESSWIRE
    12 Oct 2022
    Share Share
    New Data Show Meaningful Improvements for AD504 in Obstructive Sleep Apnea
    New Data Show Meaningful Improvements for AD504 in Obstructive Sleep Apnea

    02 Jun 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220602005151/en

    BUSINESSWIRE
    02 Jun 2022
    Share Share
    OWP Pharma Announces IND Authorization for the 1st-Ever Oral Liquid Formulation
    OWP Pharma Announces IND Authorization for the 1st-Ever Oral Liquid Formulation

    17 Nov 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/11/17/2336301/0/en/OWP-Pharmaceuticals-Announces-IND-Authorization-for-the-First-Ever-Oral-Liquid-Formulation-of-Atomoxetine-Hydrochloride-for-the-Treatment-of-Attention-Deficit-Hyperactivity-Disorde.html

    GLOBENEWSWIRE
    17 Nov 2021
    Share Share
    Apnimed sees positives in new sleep apnea drug data
    Apnimed sees positives in new sleep apnea drug data

    14 Oct 2021

    // Ben Adams FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/apnimed-sees-positives-midstage-data-for-its-attempt-at-drugging-sleep-apnea-problem

    Ben Adams FIERCEBIOTECH
    14 Oct 2021
    Share Share